デフォルト表紙
市場調査レポート
商品コード
1674118

組織工学市場:移植タイプ別、材料タイプ別、用途別、地域別

Tissue Engineering Market, By Graft Type, By Material Type, By Application, By Geography


出版日
ページ情報
英文 175 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
組織工学市場:移植タイプ別、材料タイプ別、用途別、地域別
出版日: 2025年02月14日
発行: Coherent Market Insights
ページ情報: 英文 175 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の組織工学市場は、2025年には130億2,000万米ドルと推定され、2032年には289億7,000万米ドルに達すると予測され、2025~2032年のCAGRは12.1%で成長する見込みです。

レポート範囲 レポート詳細
基準年 2024年 2025年の市場規模 130億2,000万米ドル
実績データ 2020~2024年 予測期間 2025~2032年
予測期間:2025~2032年のCAGR 12.10% 2032年の金額予測 289億7,000万米ドル
図.組織工学市場の地域別シェア(%)(2025年)
Tissue Engineering Market-IMG1

組織工学は、組織機能を回復、維持、改善するための生物学的代替物の開発に向けて、工学と生命科学の原理を応用する学際的セグメントです。新しい組織の成長をサポートする骨格と呼ばれる生物学的に不活性な材料にヒト細胞を播種することが含まれます。組織工学市場には、損傷した組織や臓器の修復や置換に使用される様々な製品の研究開発、製造が含まれます。慢性疾患の有病率の上昇、筋骨格系障害を患う高齢者の増加、技術の進歩が、この市場の需要を煽る主要要因です。しかし、組織工学製品に関連する高コストや、生体材料や幹細胞の使用に関連する倫理的問題が、市場拡大を制限しています。

市場力学

世界の組織工学市場は、がんや心血管疾患などの慢性疾患の罹患率の増加により、組織置換療法に対する高い需要が生じています。整形外科的疾患に罹患しやすい高齢者の世界の急増も、主要な市場促進要因のひとつです。世界保健機関(WHO)によると、世界の60歳以上人口の割合は2015~2050年の間に12%から22%へとほぼ倍増します。さらに、再生医療セグメントにおける継続的な技術進歩により、幹細胞、生分解性骨格、遺伝子治療技術による新しい組織工学製品の開発が可能になりました。これによって、組織工学治療の応用範囲が広がっています。しかし、組織工学的処置や生体材料の加工にかかる高いコストや、幹細胞研究に関する規制上の問題が、この市場の大きな障壁となっています。また、複雑な組織工学手術を行う熟練した専門家の不足も市場成長の課題となっています。骨格となる生体材料の製造コストを下げることに焦点を当てた研究開発が進行中であり、個別化医療アプローチの採用が利害関係者に有利な機会を提示しています。

本調査の主要特徴

  • 本レポートは、世界の組織工学市場を詳細に分析し、2024年を基準年とした予測期間(2025~2032年)の市場規模と複合年間成長率(CAGR%)を提供しています。
  • また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案マトリックスについて解説しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 世界の組織工学市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。
  • 主要企業には、Acelity L.P. Inc.、AbbVie Inc.、B. Braun SE、BioMimetic Therapeutics、Bio Tissue Technologies、C. R. Bard、International Stem Cell、Integra Lifesciences、Organogenesis Inc.、Osiris Therapeutics、RTI surgical, Inc.、Tissue Regenix Group Plc.、Zimmer Biometなどがあります。
  • このレポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、製品タイプのアップグレード、市場拡大、マーケティング戦術に関して、情報に基づいた意思決定を行うことができます。
  • 世界の組織工学市場は、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者に対応しています。
  • 世界の組織工学市場分析に使用される様々な戦略マトリックスを通じて、利害関係者は意思決定が容易になります。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • 一貫型機会マップ(COM)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 影響分析
  • 市場動向
  • 規制シナリオ
  • メーカー収益
  • 買収と提携のシナリオ
  • 製品の発売/承認
  • 資金調達と投資
  • PEST分析
  • ポーターの分析

第4章 世界の組織工学市場-コロナウイルス(COVID-19)パンデミックの影響

  • 全体的な影響
  • 政府の取り組み
  • COVID-19による市場への影響

第5章 世界の組織工学市場、移植タイプ別、2020~2032年(10億米ドル)

  • イントロダクション
  • 同種移植
  • 自家移植
  • 異種移植

第6章 世界の組織工学市場、材料タイプ別、2020~2032年(10億米ドル)

  • イントロダクション
  • 合成
  • 生物学的
  • その他

第7章 世界の組織工学市場、用途別、2020~2032年(10億米ドル)

  • イントロダクション
  • 皮膚
  • 整形外科
  • 歯科
  • 神経学
  • その他

第8章 世界の組織工学市場、地域別、2020~2032年(10億米ドル)

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第9章 競合情勢

  • 企業プロファイル
    • Acelity LP Inc.
    • AbbVie Inc.
    • B. Braun SE
    • BioMimetic Therapeutics
    • Bio Tissue Technologies
    • CR Bard
    • International Stem Cell
    • Integra Lifesciences
    • Organogenesis Inc.
    • Osiris Therapeutics
    • RTI surgical, Inc.
    • Tissue Regenix Group Plc.
    • Zimmer Biomet

第10章 アナリストの視点

  • 隆盛と衰退
  • 一貫型機会マップ

第11章 参考文献と調査手法

  • 参考文献
  • 調査手法
目次
Product Code: CMI2217

Global Tissue Engineering Market is estimated to be valued at USD 13.02 Bn in 2025 and is expected to reach USD 28.97 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 13.02 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.10% 2032 Value Projection: USD 28.97 Bn
Figure. Tissue Engineering Market Share (%), By Region 2025
Tissue Engineering Market - IMG1

Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences towards developing biological substitutes to restore, maintain, or improve tissue function. It involves seeding human cells onto biologically inert materials called scaffolds that can support new tissue growth. The tissue engineering market involves the research, development, and manufacturing of various products used for repairing or replacing damaged tissues and organs. Rising prevalence of chronic diseases, growth in geriatric population suffering from musculoskeletal disorders, and technological advancements are the major factors fueling demand in this market. However, high costs associated with tissue engineering products and ethical issues related to the use of biomaterials and stem cells limits market expansion.

Market Dynamics:

The global tissue engineering market is driven by the increasing incidence of chronic diseases such as cancer and cardiovascular diseases that generate high demand for tissue replacement therapies. Rapid growth in geriatric population worldwide who are highly prone to orthopedic conditions is another key market driver. According to World Health Organization, the proportion of world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. Furthermore, continuous technological advancements in the field of regenerative medicine has enabled development of novel tissue engineered products based on stem cells, biodegradable scaffolds, and gene therapy techniques. This has expanded applications of tissue engineering therapy. However, high costs of tissue engineering procedures, biomaterial processing and regulatory issues pertaining to stem cell research act as major barriers to the market. Lack of skilled professionals to perform complex tissue engineering surgeries also challenges market growth. Nonetheless, ongoing R&D focused on lowering manufacturing costs of scaffold biomaterials and adoption of personalized medicine approach presents lucrative opportunities for stakeholders.

Key Features of the Study:

  • This report provides an in-depth analysis of the global tissue engineering market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global tissue engineering market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Acelity L.P. Inc., AbbVie Inc., B. Braun SE, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Tissue Regenix Group Plc., and Zimmer Biomet.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global tissue engineering market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue engineering market.

Detailed Segmentation-

  • By Graft Type:
    • Allografts
    • Autografts
    • Xenografts
  • By Material Type:
    • Synthetic
    • Biological
    • Others
  • By Application:
    • Dermal
    • Orthopedic
    • Dental
    • Neurology
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Acelity L.P. Inc.
    • AbbVie Inc.
    • Braun SE
    • BioMimetic Therapeutics
    • Bio Tissue Technologies
    • C.R. Bard
    • International Stem Cell
    • Integra Lifesciences
    • Organogenesis Inc.
    • Osiris Therapeutics
    • RTI surgical, Inc.
    • Tissue Regenix Group Plc.
    • Zimmer Biomet

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Graft Type
    • Market Snapshot, By Material Type
    • Market Snapshot, By Application
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Tissue Engineering Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Tissue Engineering Market, By Graft Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Allografts
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Autografts
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Xenografts
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Tissue Engineering Market, By Material Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Synthetic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biological
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Tissue Engineering Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Dermal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Orthopedic
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Dental
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neurology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Tissue Engineering Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Graft Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Acelity L.P. Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • AbbVie Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • B. Braun SE
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BioMimetic Therapeutics
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bio Tissue Technologies
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • C. R. Bard
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • International Stem Cell
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Integra Lifesciences
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Organogenesis Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Osiris Therapeutics
    • RTI surgical, Inc.
    • Tissue Regenix Group Plc.
    • Zimmer Biomet

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact